| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |